Browsing: Journals > CNS Oncology
Read further about valproic acid and glioblastma in this article from our partner journal CNS Oncology.
Explore biomarkers of response to small-molecule therapeutics in glioblastoma in this article from our partner journal CNS Oncology.
This case study from CNS Oncology reports a 37-year-old woman’s case with recurrent and rapidly progressive VHL-associated hemangioblastomas, causing severe disability.
This article reviews what is known regarding descriptive and interventional work in neuro-oncology caregiving and highlights avenues for future research.
This review article from our partner journal CNS Oncology discusses intratumor heterogeneity of glioblastoma and the use of imaging modalities to monitor this dynamic state.
Oncology Central Ambassador Marc Chamberlain writes for CNS Oncology on a study of the use of BRAF inhibitor dabrafenib in a small group of patients with refractory ganglioglioma.
Co-authored by Oncology Central Ambassadors Simon Lo and Arjun Sahgal, this editorial approaches the topic of stereotactic radiosurgery, focusing on its potential role as a definitive therapy.